British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after reports of patients developing a rare neurological disorder.

New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

Valley man spreading awareness about Guillain-Barré Syndrome Guillain-Barré Syndrome is a condition that attacks a person's nerves. It can lead to muscle weakness and sometimes paralysis.

As it advances a monoclonal antibody targeting Guillain-Barré syndrome, Annexon is embarking on another effort to improve treatment of the condition.

Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.

In a major relief for patients diagnosed with Guillain-Barré Syndrome (GBS), the Pune Municipal Corporation (PMC) has extended its financial assistance for the affected until March 31. The move ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.

A phase 3 trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a case of neurological disorder.

Following the recent outbreak of Guillain-Barre Syndrome (GBS), a rare neurological condition in Pune, the Health Department has included Intravenous Immunoglobulin (IVIG) therapy for the ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said health experts on Monday, even as the reported cases spike in Pune ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder where the immune system attacks the peripheral nervous system, affecting muscle control and sensory signals.

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barr Syndrome (GBS), said health experts on Monday, even as the reported cases spike to over a hundred in Pune, Maharashtra.